Bain Capital Life Sciences Investors, LLC Q1 2023 Filing

Filed May 15, 2023

Portfolio Value

$800.1B

Holdings

34

Report Date

Q1 2023

Filing Type

13F-HR

All Holdings (34 positions)

#StockSharesValue% PortfolioType
1
NAMSNEWAMSTERDAM PHARMA COMPANY
8,300,000$110.1B13.76%
2
NUVLNUVALENT INC
3,577,267$93.3B11.66%
3
SWTXSPRINGWORKS THERAPEUTICS INC
3,081,307$79.3B9.91%
4
IRONDISC MEDICINE INC
1,990,914$42.2B5.27%
5
NTRANATERA INC
700,197$38.9B4.86%
6
DVAXDYNAVAX TECHNOLOGIES CORP
3,915,000$38.4B4.80%
7
CRNXCRINETICS PHARMACEUTICALS IN
2,305,558$37.0B4.63%
8
MERSANA THERAPEUTICS INC
8,663,673$35.6B4.45%
9
ARQTARCUTIS BIOTHERAPEUTICS INC
3,000,000$33.0B4.12%
10
ACRSACLARIS THERAPEUTICS INC
3,400,000$27.5B3.44%
11
PHVSPHARVARIS N V
3,180,601$25.6B3.20%
12
YB4PSAVARA INC
11,622,598$22.7B2.83%
13
CBAYUSDCYMABAY THERAPEUTICS INC
2,500,000$21.8B2.72%
14
CTIC1USDCTI BIOPHARMA CORP
4,702,996$19.8B2.47%
15
EQRX INC
10,003,573$19.4B2.43%
16
ANNXANNEXON INC
4,886,616$18.8B2.35%
17
NRIXNURIX THERAPEUTICS INC
1,822,883$16.2B2.02%
18
SLDBSOLID BIOSCIENCES INC
3,130,422$14.8B1.85%
19
TSVT*2SEVENTY BIO INC
1,408,901$14.4B1.80%
20
RPIDRAPID MICRO BIOSYSTEMS INC
8,434,560$11.0B1.38%
21
CARAEURCARA THERAPEUTICS INC
2,204,449$10.8B1.35%
22
ASNSUSDX4 PHARMACEUTICALS INC
12,202,510$10.6B1.33%
23
MRNS*MARINUS PHARMACEUTICALS INC
1,431,058$9.9B1.23%
24
XLOXILIO THERAPEUTICS INC
2,805,413$8.9B1.11%
25
AVIRATEA PHARMACEUTICALS INC
2,485,638$8.3B1.04%
26
TNGXTANGO THERAPEUTICS INC
1,921,790$7.6B0.95%
27
SYRSSYROS PHARMACEUTICALS INC
2,124,694$5.7B0.71%
28
NAUTNAUTILUS BIOTECHNOLOGY INC
2,000,000$5.5B0.69%
29
CCCCC4 THERAPEUTICS INC
1,642,210$5.2B0.64%
30
THRDTHIRD HARMONIC BIO INC
640,631$2.6B0.33%
31
IVVDINVIVYD INC
1,937,207$2.3B0.29%
32
AGLEUSDAEGLEA BIOTHERAPEUTICS INC
5,347,689$1.6B0.19%
33
APTINYX INC
8,891,758$1.1B0.14%
34
NAMSNEWAMSTERDAM PHARMA COMPANY
100,000$184.0M0.02%